Surgically induced uremia in rats I: Effect on bone strength and metabolism

Bioscience Reports

Volumn 13, Issue 5, 1993, Pages 275-287

  Jablonski, G ^a,b   Klem, K H ^a   Attramadal, A ^c   Dahl, E ^c   Ronningen H ^a   Gautvik, K M ^a,b   Haug, E ^d   Gordeladze, J O ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

1,25 dihydroxyvitamin D3; bone strength; hyperparathyroidism; osteitis fibrosa; osteomalacia; Renal osteodystrophy

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; CALCIUM; ELECTROLYTE; PARATHYROID HORMONE; PHOSPHATE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE STRENGTH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HYPERPARATHYROIDISM; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; RAT; RENAL OSTEODYSTROPHY; UREMIA;

ALKALINE PHOSPHATASE; ANIMAL; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; CHOLECALCIFEROL; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; FEMALE; HYDROXYPROLINE; HYPERPARATHYROIDISM, SECONDARY; NEPHRECTOMY; PARATHYROID HORMONES; RATS; RATS, WISTAR; RENAL OSTEODYSTROPHY; SECOND MESSENGER SYSTEMS; STRESS, MECHANICAL; SUPPORT, NON-U.S. GOV'T; UREMIA;

ANIMALIA;

EID: 0027136704     PISSN: 01448463     EISSN: 15734935     Source Type: Journal    
DOI: 10.1007/BF01137964     Document Type: Article

References (49)

1. Renal osteodystrophy
2. Review: Renal osteodystrophy, pathogenesis and treatment
3. Parathyroid hormone: chemistry, biosynthesis, and mode of action
4. Rickets, osteomalcia, and renal osteodystrophy—an update
5. The actions of parathyroid hormone on bone, relation to bone remodeling and turnover calcium homeostasis and metabolic bone disease
6. Intestinal calcium absorption: mechanisms and applications
7. Vitamin D: metabolites and biological action
8. Effects of 1 alpha-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on bone remodeling
9. Long-term administration of Vitamin D3 metabolites Alters PTH-Responsive Osteoblastic Adenylate Cyclase in Rats
10. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat
11. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D
12. Regulation of parathyroid hormone synthesis in chronic renal failure in rats
13. Renal Osteodystrophy
14. Uremic osteodystrophy: Classification, cause and treatment
15. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD
16. Renal osteodystrophy
17. In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth
18. Quantitative histological studies on the pathogenesis of uremic bone disease
19. Validation of radioreceptor assay for 1,25-dihydroxyvitamin D using selected iorn monitoring GC-MS
20. Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis of hyperparathyroidism
21. A simple procedure for determination of hydroxyproline in urine and bone
22. Methods for testing the mechanical properties of the rat femur
23. Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects
24. Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee
25. Importance of proteins in the deterioration of remnant kidney, independently of other nutrients
26. Uremic rat model: Experience with young rats
27. Partial nephrectomy and chronic renal failure: the “adult” rat model
28. Experimental chronic renal failure in rat by electrocoagulation of the cortex
29. Skeletal respons to treatment with 1,25-dihydroxy-vitamin D in renal failure
30. Renal osteodystrophy: pathophysiology and treatment
31. Osteodystrophy in experimental uremia
32. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients
33. Renal bone disease in chronic uremic rats
34. Relationship between plasam vitamin D metabolites and dietary intake of phosphate in patients with early renal failure
35. Altered divalent ion metabolism in early renal failure. Role of 1,25(OH)2D3
36. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency
37. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency
38. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure
39. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calicum and calcitriol
40. The Pathogenesis of secondary hyperparathyroidism of renal failure. Is there a controversy?
41. Effect of parathyroid hormone on myocardial energy metabolism in the rat
42. Skeletal resistance to parathyroid hormone in renal failure
43. Reversal of skeletal resistance to parathyroid hormone in renal failure
44. Is skeletal response to parathyroid hormone abnormal in experimetnal renal failure?
45. Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failure
46. Biology of disease. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances